A business in context

VYGR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-20 · 0001193125-26-427224 · Items 5.02,9.01

  2. 8-K · Current report

    Report date 2026-08-06 · 0001640266-26-000007 · Items 2.02,9.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001640266-26-000006

  4. 8-K · Current report

    Report date 2026-07-13 · 0001104659-26-082906 · Items 8.01

  5. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072934

  6. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072927

  7. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072926

  8. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072924

  9. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072923

  10. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072922

  11. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072921

  12. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072919

  13. 8-K · Current report

    Report date 2026-06-09 · 0001104659-26-072324 · Items 5.03,5.07,9.01

  14. 8-K · Current report

    Report date 2026-06-01 · 0001104659-26-068591 · Items 8.01

  15. 8-K · Current report

    Report date 2026-05-07 · 0001104659-26-057115 · Items 2.02,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-057097

  17. DEF 14A · Proxy statement

    Report date 2026-06-09 · 0001104659-26-050297

  18. 8-K · Current report

    Report date 2026-04-15 · 0001104659-26-045997 · Items 5.02

  19. 8-K · Current report

    Report date 2026-03-09 · 0001104659-26-025201 · Items 2.02,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-025197

  21. 8-K · Current report

    Report date 2026-02-09 · 0001104659-26-013897 · Items 5.02,8.01

  22. 8-K · Current report

    Report date 2026-01-08 · 0001104659-26-001955 · Items 7.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-108846

  24. 8-K · Current report

    Report date 2025-11-10 · 0001104659-25-108841 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-09-02 · 0001104659-25-085977 · Items 7.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010511

  27. 8-K · Current report

    Report date 2025-08-06 · 0001558370-25-010507 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-06-03 · 0001104659-25-056835 · Items 5.02,5.07,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-006484

  30. 8-K · Current report

    Report date 2025-05-06 · 0001558370-25-006482 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-06-03 · 0001558370-25-005254

  32. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-002703

  33. 8-K · Current report

    Report date 2025-03-11 · 0001558370-25-002702 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-02-11 · 0001104659-25-011155 · Items 8.01

  35. SC 13G/A · Ownership disclosure

    0001172661-24-005316

  36. SC 13G/A · Ownership disclosure

    0000935836-24-000721

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001558370-24-015304

  38. 8-K · Current report

    Report date 2024-11-12 · 0001558370-24-015299 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2024-09-03 · 0001104659-24-097152 · Items 1.01

  40. SC 13G/A · Ownership disclosure

    0001086364-24-008406

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001640266Voyager Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Voyager Therapeutics (United States) · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$80.00M$85.93M
2023-12-31$250.01M$276.44M
2022-12-31$40.91M$47.09M
2021-12-31$37.41M$46.52M
2020-12-31$171.13M$222.79M
2019-12-31$104.39M$137.57M
2018-12-31$7.62M$10.22M
2017-12-31$10.13M$13.93M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗